Shannon N Foster1, Shana L Hansen2, Nicholas J Scalzitti2, Panagiotis Matsangas3, Brian A Moore4,5, Vincent Mysliwiec2. 1. Department of Sleep Medicine, San Antonio Military Medical Center, 1100 Wilford Hall Loop, Lackland AFB, San Antonio, TX, 78236, USA. shannon.n.foster3.mil@mail.mil. 2. Department of Sleep Medicine, San Antonio Military Medical Center, 1100 Wilford Hall Loop, Lackland AFB, San Antonio, TX, 78236, USA. 3. Operations Research Department, Naval Postgraduate School, Monterey, CA, 93943, USA. 4. University of Texas Health Science Center at San Antonio, 7550 I-10 West, San Antonio, TX, 78229, USA. 5. University of Texas at San Antonio, One UTSA Circle, San Antonio, TX, 78249, USA.
Abstract
PURPOSE: Patients with obstructive sleep apnea (OSA) commonly report residual excessive daytime sleepiness (EDS) despite treatment with positive airway pressure (PAP). The present study aimed to determine whether patients presenting with subjective sleepiness after treatment with PAP therapy had objective evidence of residual sleepiness. METHODS: We conducted a retrospective analysis of 29 adults with OSA on PAP therapy who underwent a standardized evaluation for EDS. Patients were evaluated with the Epworth Sleepiness Scale (ESS) and attend an in-lab polysomnogram (PSG) with PAP followed by a multiple sleep latency test (MSLT). RESULTS: Our cohort consisted of 23 men (79%) and 6 women (21%) with a mean age of 40.7 years. All patients were subjectively sleepy with an ESS score of > 10 and met minimal PAP usage of 4 h a night for at least 70% of nights with a residual apnea-hypopnea index (AHI) ≤ 10. On MSLT, 31% of patients had an average sleep onset latency (SOL) < 8 min, 35% had a SOL between 8 and 11 min, and 35% had SOL > 11 min. CONCLUSION: After optimizing PAP therapy and sleep in patients with OSA and residual EDS, the majority were found to have objective findings of an abnormally short SOL on MSLT. This is further evidence that there is a distinct OSA phenotype that will have persistent EDS despite appropriate treatment of their sleep-disordered breathing. Objective testing to quantify the degree of sleepiness is recommended for OSA patients with residual EDS.
PURPOSE:Patients with obstructive sleep apnea (OSA) commonly report residual excessive daytime sleepiness (EDS) despite treatment with positive airway pressure (PAP). The present study aimed to determine whether patients presenting with subjective sleepiness after treatment with PAP therapy had objective evidence of residual sleepiness. METHODS: We conducted a retrospective analysis of 29 adults with OSA on PAP therapy who underwent a standardized evaluation for EDS. Patients were evaluated with the Epworth Sleepiness Scale (ESS) and attend an in-lab polysomnogram (PSG) with PAP followed by a multiple sleep latency test (MSLT). RESULTS: Our cohort consisted of 23 men (79%) and 6 women (21%) with a mean age of 40.7 years. All patients were subjectively sleepy with an ESS score of > 10 and met minimal PAP usage of 4 h a night for at least 70% of nights with a residual apnea-hypopnea index (AHI) ≤ 10. On MSLT, 31% of patients had an average sleep onset latency (SOL) < 8 min, 35% had a SOL between 8 and 11 min, and 35% had SOL > 11 min. CONCLUSION: After optimizing PAP therapy and sleep in patients with OSA and residual EDS, the majority were found to have objective findings of an abnormally short SOL on MSLT. This is further evidence that there is a distinct OSA phenotype that will have persistent EDS despite appropriate treatment of their sleep-disordered breathing. Objective testing to quantify the degree of sleepiness is recommended for OSA patients with residual EDS.
Authors: Bernie Y Sunwoo; Nicholas Jackson; Greg Maislin; Indira Gurubhagavatula; Charles F George; Allan I Pack Journal: Sleep Date: 2012-01-01 Impact factor: 5.849
Authors: Nick A Antic; Peter Catcheside; Catherine Buchan; Michael Hensley; Matthew T Naughton; Sharn Rowland; Bernadette Williamson; Samantha Windler; R Doug McEvoy Journal: Sleep Date: 2011-01-01 Impact factor: 5.849
Authors: Yun Li; Alexandros N Vgontzas; Julio Fernandez-Mendoza; Ilia Kritikou; Maria Basta; Slobodanka Pejovic; Jordan Gaines; Edward O Bixler Journal: Sleep Date: 2017-02-01 Impact factor: 5.849
Authors: Paula K Schweitzer; Kingman P Strohl; Geert Mayer; Russell Rosenberg; Patricia Chandler; Michelle Baladi; Lawrence Lee; Atul Malhotra Journal: J Clin Sleep Med Date: 2021-04-01 Impact factor: 4.062